OLIVIA DARWIN: Open Payments
NPI 1083279376 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 74 payments from 19 companies in 2025. Trend: 2023 $2,318 · 2024 $1,926 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $292 |
| Janssen Biotech, Inc. | 11 | $270 |
| Regeneron Healthcare Solutions, Inc. | 6 | $170 |
| Boston Scientific Corporation | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $113 |
| Ardelyx, Inc. | 5 | $95 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| GENZYME CORPORATION | 3 | $74 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Aimmune Therapeutics, Inc. | 3 | $52 |
Products named: TREMFYA, DUPIXENT, RINVOQ, LUX-Dx Insertable Cardiac Monitor, XIFAXAN, IBSRELA, IQIRVO, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
